The Oprah Podcast
The Oprah Podcast

Oct 13, 2026 · 49 min

Menopause research confronts medicine’s knowledge gap

What Every Woman (and Man Who Knows Her) Needs to Know About Menopause

The episode connects menopause symptoms to hormonal, neurological, bone, relational, and medical-care questions that remain widely misunderstood.

3 key takeaways
  1. 1Perimenopause is a fluctuating hormonal transition, not a smooth decline, and symptoms can span sleep, mood, cognition, and physical health.
  2. 2The Women's Health Initiative reshaped hormone-therapy prescribing, while its limitations continue to influence patient and clinician decisions.
  3. 3Brain, bone, and relationship health all benefit from earlier information, informed advocacy, supportive care, and prevention-focused habits.

Don't miss

Lisa Mosconi’s description of menopause as a neurological renovation reframes brain fog and cognitive change as part of a major neuroendocrine transition.

The brief

Oprah and Pilar Guzmán open with a case for reliable menopause information, drawing on personal symptoms and the public storytelling that has helped reduce shame.

Mary Claire Haver describes perimenopause as a fluctuating “zone of chaos” and revisits how the Women's Health Initiative helped create lasting fear around hormone therapy.

The discussion widens from treatment to prevention: bone loss can begin in midlife, while strength training, muscle health, and appropriate care matter especially when GLP-1 medications enter the picture.

Lisa Mosconi frames menopause as a neurological renovation, linking brain fog to mental fatigue while emphasizing uncertainty around Alzheimer's risk and the need for stronger research.

The closing argument is social as well as medical: informed partners, trustworthy communities, and self-advocacy can change how women navigate symptoms and relationships.

Books & mentions

Some links are affiliate links — PodLume may earn a commission if you buy.

Listen to the full episode and explore every guest, topic, and moment on PodLume.